Contact this trialFirst, we need to learn more about you.
Alkylating agents
FOLFOXIRI + Panitumumab for Colorectal Cancer
Recruiting3 awardsPhase 2
New Haven, Connecticut
This trial is testing a new cancer treatment for people with RAS WT advanced adenocarcinoma of the colon or rectum who have not had any prior systemic therapy for metastatic disease.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service